IDSA FOUNDATION NEWSLETTER
Our Monthly Newsletter provides highlights from our top news and information regarding latest initiatives.
Introducing the Hispanics in ID Executive Conference Room
The IDSA Foundation is proud to announce the new Hispanics in ID Executive Conference Room! Each year, the room will honor an ID specialist who has demonstrated a deep commitment to mentorship and engagement of Hispanic medical students throughout their career. Donations made to the conference room fund will be directly invested into opportunities for Hispanic medical students, including grant funding to attend IDWeek.
The 2021 inaugural dedication is in memoriam of infectious diseases physician Francisco Marty, MD. Learn more about the initiative and Dr. Marty’s work in our latest blog post.
The IDSA Foundation is proud to honor Upinder Singh, MD, FIDSA, as a 2021 Women of ID honoree. Dr. Singh lived on three different continents by the age of 13, soaking in the varying social fabrics and priorities of each culture. As she got older, she realized her unique background could bring a new perspective to global health, and the broad impact she felt she could make by pairing that experience with the field of infectious diseases excited her.
Read more about her journey in infectious diseases, the mentors and women who inspired her along the way and what she hopes to see for the future of the field.
Kicking off the new Dr. John G. Bartlett Series
with C. diff Awareness
The IDSA Foundation and Seres Therapeutics are excited to announce the launch of the new Dr. John G. Bartlett Education Series. This monthly series of exciting talks will kick off on Thursday, Nov. 18, with a webinar to raise awareness of new progress in understanding the pathogenesis of Clostridioides difficile, which John G. Bartlett, MD, FIDSA, discovered in 1978. To kick off this new initiative, Mark Wilcox, MD, FRCPath, head of research and development in microbiology at the Leeds Teaching Hospitals NHS Trust, and one of the most prolific authors and researchers in this field, will speak on pathogenesis of disease. In addition, Kathy Bischoff, a C. diff survivor and volunteer health advocate at the C Diff Foundation will speak of her personal experience with this devastating infection. Eliot Godofsky, MD, FACP, FIDSA, CEO of Bach & Godofsky, who worked closely with Dr. Bartlett for decades, will give his own personal perspective on the legacy of Dr. Bartlett and his mentorship of many.
The Foundation will release monthly lectures as part of the John G. Bartlett Education Series, which is dedicated to the thought leadership and groundbreaking work of Dr. Bartlett. In honor of his career as a pioneer in infectious diseases, the series will feature lectures by esteemed ID professionals and patient advocates in the areas of HIV, COVID-19, antimicrobial drug resistance and more. The series also includes previously-recorded talks by Dr. Bartlett on various infectious diseases, including the story behind the elimination of the deadly scourge of smallpox, now only a historic footnote due to a successful vaccination program. We are excited to launch this new series with Seres Therapeutics.
More information will be available on our website in the coming weeks. Stay tuned for more details!
Innovation and Opportunities in ID
Watch the 2021 IDea Incubator Competition on Demand
Apply for the IDSA Foundation/HIVMA Clinical Fellowship Program
Apply now for the 2022-2023 HIVMA Clinical Fellowship Program. This program supports physicians who are not yet trained in infectious diseases in pursuing one year of HIV clinical training under the mentorship of an HIVMA member at clinical sites serving medically underserved populations. Applications close Dec. 13.
The IDSA Foundation’s Industry Partners ensure our work continues for years to come. Thanks to our generous supporters, we can support life-saving research, fund innovative programs and cultivate the next generation of diverse infectious diseases professionals. We’re proud to highlight our Industry Partners to showcase what they do best. This month, we’re putting the spotlight on Janssen:
Through science and innovation, Janssen Infectious Diseases & Vaccines aims to deliver solutions to prevent, treat and cure infectious diseases. Our efforts are focused on tackling the most complex infectious diseases, finding the right paths of intervention and making sure they reach those in need. We have an ambitious goal—to ensure a future where we can prevent the spread of infectious diseases and eliminate the burden they place on global health.
Learn more about how to become an IDSA Foundation Industry Partner today!